CTO EarlyStage Biotech (Alzheimers)

An early-stage biotech developing disease?modifying therapies and early diagnostics for neurodegenerative disordersfirst focus: Alzheimersbased on a patented platform backed by 20+ years of research.
You will own the technological/clinical roadmap: translate science to clinic, design and run pre?clinical/clinical studies, interface with CROs, academia and regulators (IL/EU/US), and partner with the CEO on fundraising (grants investors) and strategy.. Requirements (Must)

PhD/MD (or equivalent) in Life Sciences/Biotech/Medicine.

Proven hands-on experience designing/managing clinical trials (preferably CNS).

Strong translational research background and familiarity with clinical operations regulations.

Excellent leadership, project management and communication skills.

Entrepreneurial mindset and willingness to start on equity compensation only until financing closes.